RKDA
Arcadia Biosciences, Inc.
+0.01 (+2.37%)0.47USD12.4K成交股數1.1M市值–本益比(近四季)0.2股價營收比-0.8%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.4M-1% | 1.1M-8% | 901K-41% | 1.3M-0% | 1.5M+47% | 1.2M+91% | 1.5M+18% | 1.3M+1% | 987K | 627K | 1.3M | 1.3M |
| 營業成本 | 812K | 700K | 708K | 884K | 824K | 682K | 1.0M | 633K | 471K | 18K | 818K | 650K |
| 毛利 | 631K0% | 400K-23% | 193K-62% | 418K-38% | 631K+22% | 518K-15% | 505K+5% | 673K+4% | 516K | 609K | 480K | 647K |
| 毛利率 | 43.7% | 36.4% | 21.4% | 32.1% | 43.4% | 43.2% | 32.9% | 51.5% | 52.3% | 97.1% | 37.0% | 49.9% |
| 研發費用 | 0 | – | 0 | 0 | 9K | 0 | 24K | 10K | 6K | −337K | 15K | 27K |
| 銷售管理費用 | 1.1M | 1.2M | 1.6M | 1.6M | 2.1M | 1.7M | 2.2M | 2.7M | 2.1M | 227K | 1.9M | 2.1M |
| 營業利益 | −496K-1% | −779K-247% | −1.4M-22% | −1.2M-158% | −501K-68% | 530K-14% | −1.8M+26% | 2.0M-236% | −1.6M | 616K | −1.4M | −1.5M |
| 營業利益率 | -34.4% | -70.8% | -152.8% | -88.5% | -34.4% | 44.2% | -114.5% | 151.6% | -160.9% | 98.2% | -107.6% | -112.1% |
| 稅後淨利 | −6.3M+41% | −4.4M-269% | −1.3M-17% | 856K-19% | −4.5M+84% | 2.6M-191% | −1.6M-37% | 1.1M+29% | −2.4M | −2.9M | −2.6M | 823K |
| 淨利率 | -434.2% | -398.6% | -148.3% | 65.7% | -306.4% | 216.6% | -104.9% | 81.2% | -245.5% | -455.8% | -197.8% | 63.5% |
| 稀釋 EPS | -2.09-36% | -2.11-211% | -0.97-18% | 0.62-21% | -3.26+83% | 1.90+124% | -1.18-38% | 0.78+28% | -1.78 | 0.85 | -1.89 | 0.61 |
| 稀釋股數 | 3.0M | 2.1M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.2M | 1.4M | 1.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.2M | 954K | 259K | 1.1M | 1.4M | 3.2M | 3.9M | 5.5M | 3.3M | 6.5M | 10.6M | 13.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | 930K | 840K | 1.2M | 1.5M | 1.5M | 1.3M | 835K | 978K | 1.8M | 837K | 2.7M | 3.2M |
| 總資產 | 5.9M | 5.3M | 6.5M | 8.6M | 7.8M | 13.0M | 15.2M | 17.4M | 16.0M | 19.7M | 23.5M | 26.8M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.3M | 2.4M | 2.4M | 3.1M | 3.3M | 4.1M | 5.1M | 5.8M | 5.6M | 7.0M | 8.1M | 9.1M |
| 股東權益 | 633K | 2.9M | 4.1M | 5.4M | 4.5M | 8.9M | 10.3M | 11.7M | 10.6M | 12.8M | 15.5M | 17.9M |
| 負債比 | 89.3% | 45.8% | 36.8% | 36.6% | 41.8% | 31.4% | 33.4% | 33.4% | 34.7% | 35.5% | 34.4% | 33.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.1M-31% | – | – | – | −1.6M | – | – | −3.2M | – | – | – |
| 資本支出 | – | – | – | – | – | 0 | – | – | 13K | – | – | – |
| 自由現金流 | – | – | – | – | – | −1.6M | – | – | −3.2M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -132.3% | – | – | -326.5% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 4.9M
| 美國 | 4.9M | 100.0% | -0.9% |
|---|
產品／服務2025 年度 · 4.9M
| 產品 | 4.9M | 100.0% | -3.1% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.9M | -3.7% | −2.3M | -48.1% | -1.71 | −4.7M |
| FY2024 | 5.0M | +13.3% | −7.0M | -139.5% | -5.17 | −9.6M |
| FY2023 | 4.5M | -40.0% | −14.0M | -314.0% | -11.29 | −15.3M |
| FY2022 | 7.4M | +9.4% | −15.4M | -207.3% | -25.65 | −14.0M |
| FY2021 | 6.8M | -15.6% | −14.7M | -216.2% | -27.56 | −26.9M |
| FY2020 | 8.0M | +587.3% | −4.7M | -57.9% | -0.47 | −32.6M |
| FY2019 | 1.2M | -20.2% | −28.8M | -2,464.1% | -4.53 | −18.7M |
| FY2018 | 1.5M | – | −13.5M | -920.8% | -3.58 | −13.9M |